QF-Pro® is currently validated for various applications and biomarkers, including:
As a versatile platform technology, QF-Pro® can be tailored to any functional protein target of interest. We work closely with clients to design and create novel functional biomarkers in a range of indications. We are constantly working to increase our off-the-shelf repertoire of biomarkers, of which you can find some examples below:
Example 1: Interaction of the immune checkpoint TIGIT/CD155 between Jurkat T cells and CHO-K1 cells.
Example 2: Activation state of Akt in clear cell renal cell carcinoma tissue.
Example 3: Interaction state of HER2/HER3 in clear cell renal cell carcinoma tissue.
Partnerships
Want to work with us? Find out about our companion diagnostics (CDx) partnership program and scientific collaborations. We have extensive collaborative networks around the world where we are running QF-Pro®-based studies.
Papers
Read our latest manuscripts to see how QF-Pro® has been used to advance translational and clinical research. Alternatively, our reviews will show you how quantitative functional proteomics can pave the way to more impactful research.
Cookies on this site are used to personalise content and adverts, provide social media features, and analyse traffic. We also share information about your use of our website with our social media, advertising and analytics partners, who may combine it with other information you have provided to them or that they have collected from your use of their services. For more information, please refer to our cookie policy.